NDC Package 60505-0251-1 Tizanidine

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

60505-0251-1

Package Description:

100 TABLET in 1 BOTTLE

Product Code:

60505-0251

Proprietary Name:

Tizanidine

Non-Proprietary Name:

Tizanidine

Substance Name:

Tizanidine Hydrochloride

Usage Information:

Tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see Dosage and Administration (2.1)].

11-Digit NDC Billing Format:

60505025101

NDC to RxNorm Crosswalk:

RxCUI: 313412 - tiZANidine HCl 2 MG Oral Tablet

RxCUI: 313412 - tizanidine 2 MG Oral Tablet

RxCUI: 313412 - tizanidine 2 MG (as tizanidine HCl 2.288 MG) Oral Tablet

RxCUI: 313413 - tiZANidine HCl 4 MG Oral Tablet

RxCUI: 313413 - tizanidine 4 MG Oral Tablet

Product Type:

Human Prescription Drug

Labeler Name:

Apotex Corp.

Dosage Form:

Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.

Administration Route(s):

Oral - Administration to or by way of the mouth.

Active Ingredient(s):

TIZANIDINE HYDROCHLORIDE 2 mg/1

Pharmacologic Class(es):

Adrenergic alpha2-Agonists - [MoA] (Mechanism of Action)

Central alpha-2 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)

Sample Package:

FDA Application Number:

ANDA076533

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

01-16-2004

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

60505 - Apotex Corp.
- 60505-0251 - Tizanidine
  - 60505-0251-1 - 100 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
60505-0251-2	1000 TABLET in 1 BOTTLE
60505-0251-3	150 TABLET in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 60505-0251-1?

The NDC Packaged Code 60505-0251-1 is assigned to a package of 100 tablet in 1 bottle of Tizanidine, a human prescription drug labeled by Apotex Corp.. The product's dosage form is tablet and is administered via oral form.

Is NDC 60505-0251 included in the NDC Directory?

Yes, Tizanidine with product code 60505-0251 is active and included in the NDC Directory. The product was first marketed by Apotex Corp. on January 16, 2004 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 60505-0251-1?

The 11-digit format is 60505025101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-4-1	60505-0251-1	5-4-2	60505-0251-01

Table of Contents